Pharmaceuticals - Community Register

  

List of nationally authorised medicinal products for human use

Rivastigmine

Product name: Rivastigmine
Active substance: Rivastigmine
Indication: Symptomatic treatment of mild to moderately severe Alzheimer's dementia.
Symptomatic treatment of mild to moderately severe dementia in patients with idiopath Parkinson's disease.
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/11/2015 PSUSA - Modification EMEA/H/C/PSUSA/2654/201501 (2015)8367 of 20/11/2015
08/03/2016 Rectificative Decision (2016)1522 of 07/03/2016